Monitor legislation related to implementation of PPACA.
Implementation of PPACA.
Patent Reform Act of 2009 (HR 1260/S515/S610).
HR4213, American Jobs and Closing Tax Loopholes Act.
Duration: November 1, 2007
to
June 30, 2010
General Issues: Health Issues , Medicare/Medicaid , Copyright/Patent/Trademark , Taxation/Internal Revenue Code
Spending: about $300,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2007: House of Representatives, U.S. Senate,, U.S. Senate, Health & Human Services - Dept of (HHS), Executive Office of the President (EOP), White House Office, Commerce - Dept of (DOC), Health & Human Services - Dept of (HHS),, Y
Y
House of Representatives; Senate; Department of Health and Human Services
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
Karen Tramontano Deputy White House Chief of Staff, Counselor to
the White House Chief of Staff.
Cecil Swamidoss Legal intern, US Senate Spec Cmte on Aging
(1998); Depty Investigator, US Sen. Spec. Cmte on
Aging (1999-2001); Investigative Counsel, US Sen
Cmte on Finance (2001); Investgative Counsel US
Sen. Spec. Cmte on Aging (2001-2003); Senior
Counsel, US Sen. Spec. Cmte on Aging (2004-
2008).
Gary Andres n/a
Darren Willcox n/a
n/a n/a n/a
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
2nd Quarter, 2010
DUTKO WORLDWIDE, LLC terminated an engagement in which they represented GENZYME on July 14, 2010.
Original Filing: 300286594.xml
Lobbying Issues
Monitor legislation related to implementation of PPACA.
Agencies Lobbied
U.S. House of Representatives
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Patent Reform Act of 2009 (HR 1260/S515/S610).
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
HR4213, American Jobs and Closing Tax Loopholes Act.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
1st Quarter, 2010
In Q1, DUTKO WORLDWIDE, LLC lobbied for GENZYME , earning $30,000. The report was filed on April 5, 2010.
Original Filing: 300254480.xml
Lobbying Issues
Monitor federal legislation related to Medicare and other health care issues and advise client as it affects them. In addition, Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Budget resolution FY2010 (bill number has not yet been assigned), Pathway for Biosimilars Act (H.R. 1548), Physician Payments Sunshine Act of 2009 (S301) & as it relates to comparative effectiveness research funding. Affordable Health Care for America Act (H.R.3962), Patient Protection and Affordable Care Act (H.R.3590), America's Affordable Health Choices Act of 2009 (H.R.3200), Affordable Health Choices Act (S.1679), America's Healthy Future Act of 2009 (S.1796).
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Health Issues/Medicaid/Patent/Trademark
4th Quarter, 2009
In Q4, DUTKO WORLDWIDE, LLC lobbied for GENZYME , earning $30,000. The report was filed on Dec. 31, 2009.
Original Filing: 300226968.xml
Lobbying Issues
Monitor federal legislation related to Medicare and other health care issues and advise client as it affects them. In addition, Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Budget resolution FY2010 (bill number has not yet been assigned), Pathway for Biosimilars Act (H.R. 1548), Physician Payments Sunshine Act of 2009 (S301) & as it relates to comparative effectiveness research funding. Affordable Health Care for America Act (H.R.3962), Patient Protection and Affordable Care Act (H.R.3590), America's Affordable Health Choices Act of 2009 (H.R.3200), Affordable Health Choices Act (S.1679), America's Healthy Future Act of 2009 (S.1796).
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Health Issues/Medicaid/Patent/Trademark
3rd Quarter, 2009
In Q3, DUTKO WORLDWIDE, LLC lobbied for GENZYME , earning $30,000. The report was filed on Oct. 1, 2009.
Original Filing: 300199845.xml
Lobbying Issues
Monitor federal legislation related to Medicare and other health care issues and advise client as it affects them. In addition, Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Budget resolution FY2010 (bill number has not yet been assigned), Pathway for Biosimilars Act (H.R. 1548), Physician Payments Sunshine Act of 2009 (S301) & as it relates to comparative effectiveness research funding. America's Affordable Health Choices Act of 2009 (H.R. 3200), Senate HELP Committee mark(no bill number assigned), Senate Finance Committee mark (no bill number assigned). Pharmaceutical import safety legislation.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Health Issues/Medicaid
Lobbying Issues
Monitor federal legislation related to health care IP issues and advise client as it affects them. In addition, Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Budget resolution FY2010 (bill number has not yet been assigned), Pathway for Biosimilars Act (H.R. 1548), Physician Payments Sunshine Act of 2009 (S301) & as it relates to comparative effectiveness research funding. America's Affordable Health Choices Act of 2009 (H.R. 3200), Senate HELP Committee mark(no bill number assigned), Senate Finance Committee mark (no bill number assigned). Pharmaceutical import safety legislation.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Copyright/Patent/Trademark
2nd Quarter, 2009
In Q2, DUTKO WORLDWIDE, LLC lobbied for GENZYME , earning $30,000. The report was filed on July 9, 2009.
Original Filing: 300174093.xml
Lobbying Issues
Monitor federal legislation related to Medicare and other health care issues and advise client as it affects them. In addition, Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Budget resolution FY2010 (bill number has not yet been assigned), Pathway for Biosimilars Act (H.R. 1548), Physician Payments Sunshine Act of 2009 (S301) & American Recovery and Reinvestment Act
of 2009 (HR1) as it relates to comparative effectiveness research funding. Health Care Reform Legislation (to date no specific bills have been introduced). Pharmaceutical import safety legislation.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Health Issues/Medicaid
Lobbying Issues
Monitor federal legislation related to patents as they relate to health care issues and advise client as it affects them. In addition, Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Budget resolution FY2010 (bill number has not yet been assigned), Pathway for Biosimilars Act (H.R. 1548), Physician Payments Sunshine Act of 2009 (S301) & American Recovery and Reinvestment Act
of 2009 (HR1) as it relates to comparative effectiveness research funding. Health Care Reform Legislation (to date no specific bills have been introduced). Pharmaceutical import safety legislation.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Copyright/Patent/Trademark
1st Quarter, 2009
In Q1, DUTKO WORLDWIDE, LLC lobbied for GENZYME , earning $30,000. The report was filed on April 9, 2009.
Original Filing: 300145414.xml
Lobbying Issues
Monitor federal legislation related to Medicare and other health care issues and advise client as it affects them. In addition, Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Budget resolution FY2010 (bill number has not yet been assigned), Pathway for Biosimilars Act (H.R. 1548), Physician Payments Sunshine Act of 2009 (S301) & American Recovery and Reinvestment Act
of 2009 (HR1) as it relates to comparative effectiveness research funding. Health Care Reform Legislation (to date no specific bills have been introduced). Pharmaceutical import safety legislation.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Health Issues/Medicaid
Lobbying Issues
Monitor federal legislation related to health care IP issues and advise client as it affects them. In addition, Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Budget resolution FY2010 (bill number has not yet been assigned), Pathway for Biosimilars Act (H.R. 1548), Physician Payments Sunshine Act of 2009 (S301) & American Recovery and Reinvestment Act
of 2009 (HR1) as it relates to comparative effectiveness research funding. Health Care Reform Legislation (to date no specific bills have been introduced). Pharmaceutical import safety legislation.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Copyright/Patent/Trademark
4th Quarter, 2008
In Q4, DUTKO WORLDWIDE, LLC lobbied for GENZYME , earning $30,000. The report was filed on Jan. 7, 2009.
Original Filing: 300114138.xml
Lobbying Issues
Monitor legislation pertaining to Medicare and other health care legislation, including Patent Reform Act of 2007 (HR 1908/ S1145), Medicare Improvements for Patients and Providers Act of 2008 (S 3101), Medicare Improvements for Patients and Providers Act of 2008 (HR 6331), Pathway for Biosimilars Act (HR 5629). Preserving Access to Laboratory Services Act of 2007.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Monitor legislation pertaining to Medicare, including Patent Reform Act of 2007 (HR 1908/S 1145), Medicare Improvements for Patients and Providers Act of 2008 (S 3101), Medicare Improvements for Patients and Providers Act of 2008 (HR 6331), Pathway for Biosimilars Act (HR 5629). Preserving Access to Laboratory Services Act of 2007.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Monitor federal legislation related to patent reform and other health care issues and advise client as it affects them. Legislation included Patent Reform Act of 2007 (HR 1908/S 1145), Medicare Improvements for Patients and Providers Act of 2008 (S 3101)
Medicare Improvements for Patients and Providers Act of 2008 (HR 6331), Pathway for Biosimilars Act (HR 5629), Preserving Access to Laboratory Services Act of 2007.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Copyright/Patent/Trademark
3rd Quarter, 2008
In Q3, DUTKO WORLDWIDE, LLC lobbied for GENZYME , earning $30,000. The report was filed on Oct. 7, 2008.
Original Filing: 300088627.xml
Lobbying Issues
Monitor legislation pertaining to Medicare and other health care legislation, including Patent Reform Act of 2007 (HR 1908/ S1145), Medicare Improvements for Patients and Providers Act of 2008 (S 3101), Medicare Improvements for Patients and Providers Act of 2008 (HR 6331), Pathway for Biosimilars Act (HR 5629). Preserving Access to Laboratory Services Act of 2007.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Monitor legislation pertaining to Medicare, including Patent Reform Act of 2007 (HR 1908/S 1145), Medicare Improvements for Patients and Providers Act of 2008 (S 3101), Medicare Improvements for Patients and Providers Act of 2008 (HR 6331), Pathway for Biosimilars Act (HR 5629). Preserving Access to Laboratory Services Act of 2007.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Monitor federal legislation related to patent reform and other health care issues and advise client as it affects them. Legislation included Patent Reform Act of 2007 (HR 1908/S 1145), Medicare Improvements for Patients and Providers Act of 2008 (S 3101)
Medicare Improvements for Patients and Providers Act of 2008 (HR 6331), Pathway for Biosimilars Act (HR 5629), Preserving Access to Laboratory Services Act of 2007.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Copyright/Patent/Trademark
2nd Quarter, 2008
In Q2, DUTKO WORLDWIDE, LLC lobbied for GENZYME , earning $30,000. The report was filed on July 8, 2008.
Original Filing: 300061587.xml
Lobbying Issues
Monitor legislation pertaining to Medicare and other health care legislation, including Patent Reform Act of 2007 (HR1908/S1145),
Medicare Improvements for Patients and Providers Act of 2008 (S 3101), Medicare Improvements for Patients and Providers Act of 2008 (HR 6331), Pathway for Biosimilars Act (HR5629). Preserving Access to Laboratory Services Act of 2007.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Monitor legislation pertaining to Medicare, including Patent Reform Act of 2007 (HR1908/S1145), Medicare Improvements for Patients and Providers Act of 2008 (S 3101), Medicare Improvements for Patients and Providers Act of 2008 (HR 6331), Pathway for Biosimilars Act (HR5629). Preserving Access to Laboratory Services Act of 2007.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Monitor federal legislation related to patent reform and other health care issues and advise client as it affects them. Legislation included Patent Reform Act of 2007 (HR1908/S1145), Medicare Improvements for Patients and Providers Act of 2008 (S 3101)
Medicare Improvements for Patients and Providers Act of 2008 (HR 6331), Pathway for Biosimilars Act (HR5629), Preserving Access to Laboratory Services Act of 2007.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Copyright/Patent/Trademark
1st Quarter, 2008
In Q1, DUTKO WORLDWIDE, LLC lobbied for GENZYME , earning $30,000. The report was filed on April 4, 2008.
Original Filing: 300032443.xml
Lobbying Issues
Monitor legislation pertaining to Medicare and other health care legislation, including Patent Reform Act of 2007 (HR1908/S1145), Medicare Reform Legislation, Pathway for Biosimilars Act (HR5629), Preserving Access to Laboratory Services Act of 2007.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Monitor legislation pertaining to Medicare, including Patent Reform Act of 2007 (HR1908/S1145), Medicare Reform Legislation, Pathway for Biosimilars Act (HR5629), Preserving Access to Laboratory Services Act of 2007.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Monitor federal legislation related to patent reform and other health care issues and advise client as it affects them. Legislation included Patent Reform Act of 2007 (HR1908/S1145), Medicare Reform Legislation, Pathway for Biosimilars Act (HR5629), Preserving Access to Laboratory Services Act of 2007.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Copyright/Patent/Trademark
0th Quarter, 2007
In MM, DUTKO WORLDWIDE, LLC lobbied for GENZYME , earning $70,000. The report was filed on Aug. 3, 2007.
Original Filing: 200045687.xml
Lobbying Issues
Monitor legislation pertaining to Medicare and other health care legislation
Agencies Lobbied
Y
Y
House of Representatives; Senate; Department of Health and Human Services
Lobbying Issues
Monitor legislation pertaining to Medicare
Agencies Lobbied
Y
Y
House of Representatives; Senate; Department of Health and Human Services
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...